The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Xenetix 250mg I/ml Solution for Injection

250
millilitre(s) Solution for injection


GuerbetPA0686/002/001

Main Information

Trade NameXenetix 250mg I/ml Solution for Injection
Active SubstancesIobitridol
Strength250
millilitre(s)
Dosage FormSolution for injection
Licence HolderGuerbet
Licence NumberPA0686/002/001

Group Information

ATC CodeV08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
V08AB11 iobitridol

Status

Authorised/WithdrawnAuthorised
Licence Issued10/10/1996
Legal statusProduct subject to Restricted Prescription (C)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back